Loading...
Loading...
SDGR| Name | Value |
|---|---|
| Revenues | 47.3M |
| Cost of Revenue | 16.0M |
| Gross Profit | 31.3M |
| Operating Expense | 84.1M |
| Operating I/L | -52.7M |
| Other Income/Expense | -1.2M |
| Interest Income | 0.0M |
| Pretax | -54.0M |
| Income Tax Expense | 0.1M |
| Net Income/Loss | -54.0M |
Schrödinger, Inc. provides a physics-based software platform for drug development and materials applications. The company operates in two segments: Software, selling its software for drug discovery in the life sciences and materials science industries, and Drug Discovery, focusing on preclinical and clinical programs. Schrödinger serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide.
